ArticleFrontiers in oncology2020

GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAF

Ruowen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.